Concepedia

Dorthe Lundsgaard

DL

Statistics

Publications

15

Citations

1.2K

H-Index

12

Active since

2001

Affiliations

Novo Nordisk (Denmark)(Current)

Peter MacCallum Cancer Centre

HistoGenetics (United States)

Seattle University

Austin Health

Dorthe Lundsgaard is an author at Novo Nordisk (Denmark) specializing in immunology, medicine, and autoimmunity.

Top concepts

Publications per year

2001–2018

15

Publications

15

Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin

Claus Johansen, P.A. Usher, Rasmus Boye Kjellerup et al. · British Journal of Dermatology · 2009 · 335 citations

An Open-Label, Two-Arm, Phase I Trial of Recombinant Human Interleukin-21 in Patients with Metastatic Melanoma

Ian D. Davis, Birte K. Skrumsager, Jonathan Cebon et al. · Clinical Cancer Research · 2007 · 164 citations · Full text

Interleukin‐21 activates human natural killer cells and modulates their surface receptor expression

Kresten Skak, Klaus Stensgaard Frederiksen, Dorthe Lundsgaard · Immunology · 2007 · 154 citations · Full text

, , +19

Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients with Stage IV Malignant Melanoma without Prior Treatment: A Phase IIa Trial

Ian D. Davis, Ben Brady, Richard Kefford et al. · Clinical Cancer Research · 2009 · 138 citations

IL-21 induces in vivo immune activation of NK cells and CD8+ T cells in patients with metastatic melanoma and renal cell carcinoma

Klaus Stensgaard Frederiksen, Dorthe Lundsgaard, Jeremy A. Freeman et al. · Cancer Immunology Immunotherapy · 2008 · 114 citations · Full text

1–5 of 15